80 related articles for article (PubMed ID: 22908771)
1. Hot topics in urological health economics. A mini review.
Racioppi M; Palermo G; D'Addessi A; Pinto F; Sacco E; D'Agostino D; Vittori M; Bassi PF
Arch Ital Urol Androl; 2012 Jun; 84(2):47-52. PubMed ID: 22908771
[TBL] [Abstract][Full Text] [Related]
2. Urologic diseases in America Project: analytical methods and principal findings.
Litwin MS; Saigal CS; Yano EM; Avila C; Geschwind SA; Hanley JM; Joyce GF; Madison R; Pace J; Polich SM; Wang M;
J Urol; 2005 Mar; 173(3):933-7. PubMed ID: 15711342
[TBL] [Abstract][Full Text] [Related]
3. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
Xie J; Namjoshi M; Wu EQ; Parikh K; Diener M; Yu AP; Guo A; Culver KW
J Manag Care Pharm; 2011 Oct; 17(8):621-43. PubMed ID: 21942303
[TBL] [Abstract][Full Text] [Related]
5. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
6. The economic costs of pain in the United States.
Gaskin DJ; Richard P
J Pain; 2012 Aug; 13(8):715-24. PubMed ID: 22607834
[TBL] [Abstract][Full Text] [Related]
7. Economics and cost of care of stone disease.
Lotan Y
Adv Chronic Kidney Dis; 2009 Jan; 16(1):5-10. PubMed ID: 19095200
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R; Leal J; Gray A; Sullivan R
Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Assessment of the Economic Burden of Upper Urinary Tract Stone Disease in the United States: Analysis of One-Year Health Care Costs, 2011-2018.
Becerra AZ; Khusid JA; Sturgis MR; Fink LE; Gupta M; Konety BR; Olweny EO
J Endourol; 2022 Apr; 36(4):429-438. PubMed ID: 34693752
[No Abstract] [Full Text] [Related]
10. Economic evaluation of extracorporeal shock wave lithotripsy, percutaneous ultrasonic lithotripsy, and standard surgical treatment of urolithiasis--a Canadian perspective.
Labelle RJ; Churchill DN; Martin S; Isbister E; Orovan W
Clin Invest Med; 1987 Mar; 10(2):86-95. PubMed ID: 3107861
[TBL] [Abstract][Full Text] [Related]
11. Breastfeeding and the U.S. economy.
Bartick M
Breastfeed Med; 2011 Oct; 6():313-8. PubMed ID: 22007819
[TBL] [Abstract][Full Text] [Related]
12. Costs of illness: United States, 1980.
Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
[TBL] [Abstract][Full Text] [Related]
13. The economic burden of prostate cancer.
Roehrborn CG; Black LK
BJU Int; 2011 Sep; 108(6):806-13. PubMed ID: 21884356
[TBL] [Abstract][Full Text] [Related]
14. All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective.
McAdam-Marx C; McGarry LJ; Hane CA; Biskupiak J; Deniz B; Brixner DI
J Manag Care Pharm; 2011 Sep; 17(7):531-46. PubMed ID: 21870894
[TBL] [Abstract][Full Text] [Related]
15. Acute coronary syndromes in Europe: 1-year costs and outcomes.
Taylor MJ; Scuffham PA; McCollam PL; Newby DE
Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
[TBL] [Abstract][Full Text] [Related]
16. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
17. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
[TBL] [Abstract][Full Text] [Related]
18. The impact of diabetes mellitus on healthcare costs in Italy.
Giorda CB; Manicardi V; Diago Cabezudo J
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
[TBL] [Abstract][Full Text] [Related]
19. The economics of health care quality and medical errors.
Andel C; Davidow SL; Hollander M; Moreno DA
J Health Care Finance; 2012; 39(1):39-50. PubMed ID: 23155743
[TBL] [Abstract][Full Text] [Related]
20. Cost impact of COPD in Japan: opportunities and challenges?
Nishimura S; Zaher C
Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
